Basic and clinical studies have demonstrated that NAFLD is associated with changes in some distinct metabolic regulators such as fibroblast growth factor 21 (FGF21), adiponectin, and irisin, which have beneficial effects on energy homeostasis20–23. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.